JP2005531563A - 抗腫瘍性多環式カルボキサミド - Google Patents

抗腫瘍性多環式カルボキサミド Download PDF

Info

Publication number
JP2005531563A
JP2005531563A JP2004505374A JP2004505374A JP2005531563A JP 2005531563 A JP2005531563 A JP 2005531563A JP 2004505374 A JP2004505374 A JP 2004505374A JP 2004505374 A JP2004505374 A JP 2004505374A JP 2005531563 A JP2005531563 A JP 2005531563A
Authority
JP
Japan
Prior art keywords
formula
compound
optionally substituted
iii
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004505374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531563A5 (https=
Inventor
チャールズ バグレイ，ブルース
ウィリアム デディー，レズリー
アレクサンダー デニー，ウィリアム
ロデマン，トーマス
レズリー ロジャース，マイケル
Original Assignee
ラトローブ ユニバーシティ
オークランド ユニサービシーズ リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラトローブ ユニバーシティ, オークランド ユニサービシーズ リミティド filed Critical ラトローブ ユニバーシティ
Publication of JP2005531563A publication Critical patent/JP2005531563A/ja
Publication of JP2005531563A5 publication Critical patent/JP2005531563A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2004505374A 2002-05-15 2003-05-12 抗腫瘍性多環式カルボキサミド Pending JP2005531563A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS2344A AUPS234402A0 (en) 2002-05-15 2002-05-15 Anti-tumour polycyclic carboxamides
PCT/AU2003/000569 WO2003097642A1 (en) 2002-05-15 2003-05-12 Anti-tumour polycyclic carboxamides

Publications (2)

Publication Number Publication Date
JP2005531563A true JP2005531563A (ja) 2005-10-20
JP2005531563A5 JP2005531563A5 (https=) 2006-06-29

Family

ID=3835914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004505374A Pending JP2005531563A (ja) 2002-05-15 2003-05-12 抗腫瘍性多環式カルボキサミド

Country Status (8)

Country Link
US (2) US7504507B2 (https=)
EP (1) EP1507778B1 (https=)
JP (1) JP2005531563A (https=)
AT (1) ATE546447T1 (https=)
AU (1) AUPS234402A0 (https=)
CA (1) CA2485494C (https=)
NZ (1) NZ537015A (https=)
WO (1) WO2003097642A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018536670A (ja) * 2015-12-08 2018-12-13 ウニヴェルシテート ツー ケルンＵｎｉｖｅｒｓｉｔａｅｔ Ｚｕ Ｋｏｅｌｎ Ｃｐａｐ−チューブリンモジュール

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS234402A0 (en) * 2002-05-15 2002-06-13 Auckland Uniservices Limited Anti-tumour polycyclic carboxamides
AU2005209845A1 (en) * 2004-01-30 2005-08-18 Chemgenex Pharmaceuticals, Inc. Naphthalimide dosing by N-acetyl transferase genotyping
US20080248134A1 (en) * 2005-05-04 2008-10-09 Auckland Uniservices Limited Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof
CZ304996B6 (cs) 2013-01-17 2015-03-18 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Deriváty helquatů, jejich příprava a použití jako léčiva
CZ307163B6 (cs) 2014-05-29 2018-02-14 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. Helquaty s heteroaromatickými substituenty, jejich příprava a použití jako stabilizátory G-kvadruplexů
CN109265396A (zh) * 2018-09-12 2019-01-25 李玮 多环酰胺化合物的合成新方法与抗癌活性
CN115677691B (zh) * 2022-08-24 2023-08-29 潍坊富邦药业有限公司 一种苯并萘啶酰胺抗癌药sn28049及其类似物的制备方法
CN118852160A (zh) * 2024-09-24 2024-10-29 世华合创生物技术开发(山东)有限公司 一种三环酰胺化合物、制备方法及应用
CN119350330B (zh) * 2024-12-23 2025-03-21 世华合创生物技术开发(山东)有限公司 一种二氮杂三环胺化合物、制备方法及其应用
CN119350329B (zh) * 2024-12-23 2025-03-21 世华合创生物技术开发(山东)有限公司 一种二氮杂三环胺化合物、制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
NZ201084A (en) * 1982-06-25 1985-10-11 New Zealand Dev Finance 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such
AUPS234402A0 (en) * 2002-05-15 2002-06-13 Auckland Uniservices Limited Anti-tumour polycyclic carboxamides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6009059752, Ｊ．Ｈｅｔｅｒｏｃｙｃｌ．Ｃｈｅｍ．，（２００１），３８（５），ｐ．１１８５−９０ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018536670A (ja) * 2015-12-08 2018-12-13 ウニヴェルシテート ツー ケルンＵｎｉｖｅｒｓｉｔａｅｔ Ｚｕ Ｋｏｅｌｎ Ｃｐａｐ−チューブリンモジュール

Also Published As

Publication number Publication date
CA2485494C (en) 2011-08-23
WO2003097642A1 (en) 2003-11-27
EP1507778A4 (en) 2006-05-31
AUPS234402A0 (en) 2002-06-13
EP1507778B1 (en) 2012-02-22
ATE546447T1 (de) 2012-03-15
US7504507B2 (en) 2009-03-17
NZ537015A (en) 2007-06-29
EP1507778A1 (en) 2005-02-23
US20090156630A1 (en) 2009-06-18
US20050245561A1 (en) 2005-11-03
CA2485494A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
US20090156630A1 (en) Anti-tumour polycyclic carboxamides
JP7289876B2 (ja) Ｒｓｋ阻害剤として有用なカルボキサミド誘導体
AU2009242279B2 (en) Spiro-indole derivatives for the treatment of parasitic diseases
JP6878615B2 (ja) Ｓｈｐ２阻害剤として有用な新規な複素環式誘導体
JP2020189868A (ja) Ｓｈｐ２阻害剤として有用な新規複素環式誘導体
AU765128B2 (en) Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
JP2022550436A (ja) 抗ウイルス性複素環化合物
JP2019517487A (ja) Ｐｔｐｎ１１の複素環式阻害剤
KR20100100771A (ko) Ｐａｒｐ 억제제 화합물, 조성물 및 사용 방법
CN110963997A (zh) 杂环酰胺类化合物、包含其的药物组合物及其制备方法和用途
EP3169687B1 (en) FUSED QUINOLINE COMPUNDS AS PI3K, mTOR INHIBITORS
CN116528871A (zh) 一种吡唑并喹唑啉类化合物、其制备方法及应用
AU2017204748B2 (en) (--)-Huperzine A processes and related compositions and methods of treatment
US6992089B2 (en) Nitro and amino substituted topoisomerase agents
CN116669725A (zh) 新型氨基吡啶及其在治疗癌症中的用途
AU2003221640B2 (en) Anti-tumour polycyclic carboxamides
PT682030E (pt) Derivados de 8-amino-10-(azabiciclo-alquil)-pirido¬1,2,3-d,e|-¬1,3,4|benzoxadiazina processo para a sua preparacao assim como agentes antibacterianos que contem estes compostos
HK1149935B (en) Spiro-indole derivatives for the treatment of parasitic diseases
HK1192885A (en) Spiro-indole derivatives for the treatment of parasitic diseases
BR112018016968B1 (pt) Composto,composição farmacêutica e uso do mesmo para preparo de um medicamento para tratamento de câncer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060512

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060512

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100223

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100727